Regency Capital Management Inc.\De Vectiv Bio Holding Ag Call Options Transaction History
Regency Capital Management Inc.\De
- $142 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VECT
# of Institutions
1Shares Held
510KCall Options Held
0Put Options Held
0About VectivBio Holding AG
- Ticker VECT
- Exchange NASDAQ
- Description
- VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...